Better Health with ALVANTIS Peptide
About Alvantis
Shenzhen Alvantis Pharma Co., Ltd. specializes in the research and development of GLP-1R Agonist Peptide(Tirzepatide and Semaglutide) and other therapeutic peptide APIs and Formulation.
Alvtantis has more than 10 years of experience in peptide synthesis, structural modification, quality research and formulation optimization. At the same time, with the United States ANDA and Chinese drugapplication experience, Alvantis has an extraordinary advantage in peptide research, DS development and DP formulations. In addition, we can provide other types of specialty chemicals or pharmaceutical products (including aseptic APIs in Vial on request) , as well as ranging from gram laboratory sizes sample to kilogram GMP level peptide.
Products
Alvantis can provide other types of specialty chemicals or pharmaceutical products (including aseptic APIs in Vials on request), as well as ranging from gram laboratory sizes to kilogram GMP levels.
Production center in Zhongshan, Guangdong Province has a GMP workshop and peptide substance manufacturing equipment such as solid-phase synthesis equipment as well as hybrid SPPS/LPPS approach, cleavage equipment, industrial preparation LC system, and freeze dryer. It can meet the pilot and pilot production needs of complex condition products and can produce 50kg of peptides per year.
Services
Customized Peptide
——
ALVANTIS specializes in synthetic cosmetic peptides, including therapeutic peptides, and modified peptides. ALVANTIS has key technological advantage in cyclic peptide, PEG modification, peptide conjugates (including CY3, CY5, ICG, biotin etc.).
Peptide Reference Materials
——
ALVANTIS Pharmaceutical can provide Peptide Reference Materials (PRM), like, Tirzepatide, Semaglutide. Also, we can provide a variety of PRM custom synthesis services. The PRM is packaged in solid powder or freeze-dried form. PRMs can be used for both qualitative and quantitative purposes.
Amino Reference Materials
——
ALVANTIS Pharmaceutical can provide Protected-amino-acid Reference Materials (ARM), to support impurity control in peptide synthesis. The ARMs were packaged in Type I borosilicate vial. ARMs can be used for both qualitative and quantitative purposes. HPLC, KF titration, amino acid ratio...
News
-
Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence
Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence
넶28 2025-01-22 -
Tirzapatide approved by FDA as first sleep apnea medication
FDA has approved Zepbound (tirzepatide) as the first and only prescription medication for adults with moderate-to-severe obstructive sleep apnea and obesity.
넶34 2025-01-21 -
Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen
Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU.
넶8 2025-01-22
Facilities
Contact
Shenzhen Alvantis Pharmaceutical Co., Ltd.
Address: Room 1902, Building D3, Nanshan Wisdom Park, No.1001, Xueyuan Avenue, Nanshan District, Shenzhen
E-mail:info@xinspharma.com
Products